# A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension

Study · id `cardio:ct-nct02277691` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02277691](<https://clinicaltrials.gov/study/NCT02277691>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02277691

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 341 participants.

## Technical summary

Registry record NCT02277691. Allocation not applicable; no masking; primary purpose treatment. Start 2014-11-07 (actual); primary completion 2016-04-25 (actual). Results posted on 2017-06-26.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 341 participants (enrolled count; ClinicalTrials.gov record NCT02277691, source copy `cardio:ctgov-nct02277691-2017-08-02`, retrieved 2026-10-26)
- Started: 2014-11-07 (actual) (ClinicalTrials.gov record NCT02277691, source copy `cardio:ctgov-nct02277691-2017-08-02`, retrieved 2026-10-26)
- Primary completion: 2016-04-25 (actual) (ClinicalTrials.gov record NCT02277691, source copy `cardio:ctgov-nct02277691-2017-08-02`, retrieved 2026-10-26)
- Completion: 2016-04-25 (actual) (ClinicalTrials.gov record NCT02277691, source copy `cardio:ctgov-nct02277691-2017-08-02`, retrieved 2026-10-26)
- Results first posted: 2017-06-26 (ClinicalTrials.gov record NCT02277691, source copy `cardio:ctgov-nct02277691-2017-08-02`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT02277691, source copy `cardio:ctgov-nct02277691-2017-08-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02277691-2017-08-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension
- Condition: Essential Hypertension
- Intervention (Drug): TAK-536TCH tablet
- Intervention (Drug): TAK-536CCB tablet
- Intervention (Drug): HCTZ 12.5 mg tablet
- Lead sponsor: Takeda
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Takeda (`cardio:org-takeda`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension (`cardio:pubmed-29235365`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2f2af60633503a4a2289b46ba37bca0b6d1397c2172b231a3a114d3d5cfbcf13
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
